TrialPath
Recruiting

Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia

NCT06893510 · Istanbul University - Cerrahpasa
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
The Effect of Virtual Reality-Based and Face-to-Face Relaxation Programs on Maternal and Fetal Outcomes in Pregnant Women With Preeclampsia
About this study
Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140/90 mmHg) after the 20th gestational week, often accompanied by proteinuria and systemic complications such as thrombocytopenia, liver dysfunction, and cerebral symptoms. This condition poses significant risks for both maternal and fetal health, increasing the likelihood of organ damage, preterm birth, and long-term cardiovascular and neurodevelopmental complications. Non-pharmacological interventions, including relaxation techniques, have been explored for symptom management. Progressive muscle relaxation (PMR) has shown efficacy in reducing stress, anxiety, and blood pressure. Recently, virtual reality (VR)-based relaxation techniques have gained attention for enhancing stress relief and improving health outcomes. This study aims to compare the effects of VR-based PMR with in-person PMR on maternal and fetal outcomes in preeclamptic pregnancies.
Eligibility criteria
Inclusion Criteria: * Hospitalized with a diagnosis of preeclampsia. * Gestational age ≥26 weeks. * 18 years or older. * Singleton and viable pregnancy. * Willing to participate in the study voluntarily. Exclusion Criteria: * Multiple pregnancy. * Pregnancy achieved through assisted reproductive technologies. * Hearing or vision impairment in the pregnant individual. * Fetal distress requiring emergency intervention. * HELLP Syndrome or Eclampsia. * History of vertigo. Withdrawal Criteria: * Cases where live birth does not occur. * Participants who voluntarily withdraw from the study. * Participants whose general health condition deteriorates during the intervention. * Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache). * Participants who do not practice progressive muscle relaxation at least once a week after the intervention.
Study design
Enrollment target: 96 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2025-09-08
Estimated completion: 2026-09-01
Last updated: 2026-06-10
Interventions
Other: Virtual Reality Based Progressive Muscle RelaxationOther: Face-to-Face Progressive Muscle Relaxation
Primary outcomes
  • • Descriptive Information Form (Day 1 (Baseline, Pre-Intervention))
  • • Maternal-Fetal Outcomes Follow-up Form (Day 1 (Baseline, Pre-Intervention), Day 2 and 3 (Post-Intervention for intervention groups, routine monitoring for the control group))
  • • Beck Anxiety Inventory (BAI) (Day 1 (Baseline, before intervention for intervention groups, before routine assessment for control group) and Day 3 (Post-intervention for intervention groups, after routine assessment for control group).)
Sponsor
Istanbul University - Cerrahpasa · other
Contacts & investigators
ContactGüzin Ünlü Suvari, M.Sc. · contact · guzin.unlu@ogr.iuc.edu.tr · +902165004429
InvestigatorErgül Aslan, Prof. Dr. · principal_investigator, İstanbul University-Cerrahpaşa
All locations (1)
Ümraniye Training and Research HospitalRecruiting
Istanbul, Turkey (Türkiye)
Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia · TrialPath